Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Lobanov (Moscow, Russian Federation), S. Andronov (Moscow, Russian Federation), E. Bogdanova (Severodvinsk, Russian Federation), A. Emelyanov (Saint-Petersburg, Russian Federation), A. Fesyun (Moscow, Russian Federation), A. Rachin (Moscow, Russian Federation), G. Barashkov (Moscow, Russian Federation), A. Nikitina (Moscow, Russian Federation), A. Popov (Nadym, Russian Federation). Prevention of COPD exacerbations using nebulization with an electrolytic silver solution. 2473

Member's Comments

No comment yet.

Related content which might interest you: Prevention of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012 Prevention and treatment of COPD exacerbations Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018 Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013 Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 214s Year: 2006 Prevention and management of COPD exacerbations Source: International Congress 2016 – China Session II Year: 2016 Efficacy of inhalation from different powder inhalators in COPD patiens with chronic respiratory failure Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006 Dry sodium chloride aerosol in rehabilitation of patients with COPD Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Tolerability of inhalation of salt particles in COPD patients Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Management of COPD exacerbations Source: ERS Lung Science Conference 2019 Year: 2019 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 Effects of sodium chloride high concentrated solution inhalations in patients with chronic non-allergic obstructive bronchopulmonary diseases Source: Annual Congress 2008 - Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients Year: 2008 Monitorization of β2-adrenergic effects in carriers of chronic obstructive pulmonary disease (COPD) using ultra-sonic and jet nebulization Source: Eur Respir J 2002; 20: Suppl. 38, 182s Year: 2002 The role of nebulised budesonide in the treatment of exacerbations of COPD Source: Eur Respir J 2007; 29: 660-667 Year: 2007 Study of adherence to the use of inhaled sodium colistimethate through the I-neb® nebulization system Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003 Impact of halotherapy on COPD exacerbations Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019